ECSP034468A - Compuesto farmaceutico novedoso - Google Patents
Compuesto farmaceutico novedosoInfo
- Publication number
- ECSP034468A ECSP034468A EC2003004468A ECSP034468A ECSP034468A EC SP034468 A ECSP034468 A EC SP034468A EC 2003004468 A EC2003004468 A EC 2003004468A EC SP034468 A ECSP034468 A EC SP034468A EC SP034468 A ECSP034468 A EC SP034468A
- Authority
- EC
- Ecuador
- Prior art keywords
- compound
- pharmaceutical compound
- new pharmaceutical
- novel
- thiazolidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0019226.0A GB0019226D0 (en) | 2000-08-04 | 2000-08-04 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034468A true ECSP034468A (es) | 2003-03-31 |
Family
ID=9897028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004468A ECSP034468A (es) | 2000-08-04 | 2003-02-04 | Compuesto farmaceutico novedoso |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1307448A1 (cs) |
| JP (1) | JP2004505971A (cs) |
| KR (1) | KR20030022356A (cs) |
| CN (1) | CN1458930A (cs) |
| AP (1) | AP2003002737A0 (cs) |
| AU (1) | AU2001276508A1 (cs) |
| BG (1) | BG107605A (cs) |
| BR (1) | BR0112984A (cs) |
| CA (1) | CA2417828A1 (cs) |
| CZ (1) | CZ2003314A3 (cs) |
| EA (1) | EA200300231A1 (cs) |
| EC (1) | ECSP034468A (cs) |
| GB (1) | GB0019226D0 (cs) |
| HU (1) | HUP0300770A2 (cs) |
| IL (1) | IL154277A0 (cs) |
| MA (1) | MA25830A1 (cs) |
| MX (1) | MXPA03001086A (cs) |
| NO (1) | NO20030508L (cs) |
| OA (1) | OA12355A (cs) |
| PL (1) | PL360702A1 (cs) |
| SK (1) | SK1452003A3 (cs) |
| WO (1) | WO2002012233A1 (cs) |
| ZA (1) | ZA200300962B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
| FR2845602B1 (fr) * | 2002-10-11 | 2005-07-08 | Servier Lab | Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent |
| US7264813B2 (en) | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
| CN102532122B (zh) * | 2010-12-29 | 2015-12-02 | 开封制药(集团)有限公司 | 酒石酸罗格列酮的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2000
- 2000-08-04 GB GBGB0019226.0A patent/GB0019226D0/en not_active Ceased
-
2001
- 2001-08-03 EA EA200300231A patent/EA200300231A1/ru unknown
- 2001-08-03 CA CA002417828A patent/CA2417828A1/en not_active Abandoned
- 2001-08-03 SK SK145-2003A patent/SK1452003A3/sk unknown
- 2001-08-03 KR KR10-2003-7001605A patent/KR20030022356A/ko not_active Application Discontinuation
- 2001-08-03 CZ CZ2003314A patent/CZ2003314A3/cs unknown
- 2001-08-03 EP EP01954161A patent/EP1307448A1/en not_active Withdrawn
- 2001-08-03 AP APAP/P/2003/002737A patent/AP2003002737A0/en unknown
- 2001-08-03 CN CN01815682A patent/CN1458930A/zh active Pending
- 2001-08-03 OA OA1200300029A patent/OA12355A/en unknown
- 2001-08-03 BR BR0112984-8A patent/BR0112984A/pt not_active IP Right Cessation
- 2001-08-03 WO PCT/GB2001/003514 patent/WO2002012233A1/en not_active Application Discontinuation
- 2001-08-03 AU AU2001276508A patent/AU2001276508A1/en not_active Abandoned
- 2001-08-03 MX MXPA03001086A patent/MXPA03001086A/es unknown
- 2001-08-03 HU HU0300770A patent/HUP0300770A2/hu unknown
- 2001-08-03 JP JP2002518208A patent/JP2004505971A/ja active Pending
- 2001-08-03 IL IL15427701A patent/IL154277A0/xx unknown
- 2001-08-03 PL PL01360702A patent/PL360702A1/xx not_active Application Discontinuation
-
2003
- 2003-01-31 NO NO20030508A patent/NO20030508L/no not_active Application Discontinuation
- 2003-02-03 MA MA27022A patent/MA25830A1/fr unknown
- 2003-02-04 EC EC2003004468A patent/ECSP034468A/es unknown
- 2003-02-04 ZA ZA200300962A patent/ZA200300962B/en unknown
- 2003-02-28 BG BG107605A patent/BG107605A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001276508A1 (en) | 2002-02-18 |
| BR0112984A (pt) | 2003-06-10 |
| JP2004505971A (ja) | 2004-02-26 |
| OA12355A (en) | 2004-03-19 |
| EP1307448A1 (en) | 2003-05-07 |
| NO20030508L (no) | 2003-03-20 |
| KR20030022356A (ko) | 2003-03-15 |
| GB0019226D0 (en) | 2000-09-27 |
| SK1452003A3 (en) | 2004-05-04 |
| WO2002012233A1 (en) | 2002-02-14 |
| HUP0300770A2 (hu) | 2003-11-28 |
| PL360702A1 (en) | 2004-09-20 |
| MA25830A1 (fr) | 2003-07-01 |
| NO20030508D0 (no) | 2003-01-31 |
| CN1458930A (zh) | 2003-11-26 |
| CZ2003314A3 (cs) | 2004-02-18 |
| MXPA03001086A (es) | 2003-05-27 |
| BG107605A (bg) | 2003-09-30 |
| ZA200300962B (en) | 2003-10-29 |
| IL154277A0 (en) | 2003-09-17 |
| EA200300231A1 (ru) | 2003-06-26 |
| AP2003002737A0 (en) | 2003-03-31 |
| CA2417828A1 (en) | 2002-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0607803A2 (pt) | forma de dosagem oral compreendendo rosiglitazona | |
| UY25304A1 (es) | Forma hidratada de maleato de rosiglitazona | |
| ECSP034469A (es) | Compuesto farmaceutico novedoso | |
| AR015894A1 (es) | Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos | |
| ECSP034468A (es) | Compuesto farmaceutico novedoso | |
| CY1105354T1 (el) | Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο | |
| AR015120A1 (es) | Composicion farmaceutica que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino) etoxi]bencil]-tiazolidin-2,4-diona, un procedimiento para su preparacion, y unacomposicion para la pre-administracion farmaceutica | |
| ECSP034467A (es) | Farmaceutico novedoso | |
| ECSP034466A (es) | Farmaceutico novedoso | |
| ECSP034505A (es) | La sal de clorhidrato de 5-[4-(2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2, 4-diona | |
| RS50136B (sr) | Derivati tiazolidindiona i njihova upotreba kao antidijabetika | |
| PT1446404E (pt) | Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos | |
| ECSP034529A (es) | Derivado de tiazolidinodiona y su uso como antidiabetico | |
| ECSP034528A (es) | Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona | |
| GB0021978D0 (en) | Novel pharmaceutical | |
| EA200300004A1 (ru) | Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата | |
| BR0111536A (pt) | Sal de tiazolidinediona para tratamento de diabetes mellitus | |
| ECSP034463A (es) | Composicion farmaceutica | |
| ECSP003434A (es) | Nuevos compuestos | |
| SI1448559T1 (sl) | 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil-tiazolidin-2,4-dion- benzensulfonat; postopek za njegovo pripravo; njegovi polimorfi i, ii, iii; in njegova uporaba kot farmacevtska uäśinkovina | |
| AR018994A1 (es) | Compuestos tiazolidindiona, un proceso para su preparacion, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento | |
| ECSP003438A (es) | Nuevos compuestos |